[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367993-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367993-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","comparative-mortality-in-heart-failure-on-guideline-directed-medical-therapy-versus-malignant-cancer-original-research","Comparative Mortality in Heart Failure on Guideline-Directed Medical Therapy Versus Malignant Cancer - Original Research","","Guideline-directed medical therapy (GDMT) has improved outcomes for heart failure with reduced ejection fraction (HFrEF), but its effect on the historically observed mortality parity between heart failure and cancer remains unclear. Using a TriNetX Global Collaborative Research Network cohort (2015–2024), the study compared all-cause mortality in patients receiving GDMT versus those not receiving full GDMT and versus patients with malignant cancers. Survival was better with GDMT across cancer overall and most sex-specific cancers, while absence of full GDMT correlated with worse outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/comparative-mortality-in-heart-failure-on-guideline-directed-medical-therapy-versus-malignant-cancer-original-research/367993/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/comparative-mortality-in-heart-failure-on-guideline-directed-medical-therapy-versus-malignant-cancer-original-research/367993.png","ImageObject",300,407,{"name":42,"@type":43},"nayy☆","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does guideline-directed medical therapy (GDMT) affect mortality versus malignant cancer in HFrEF?","Question",{"text":63,"@type":64},"Patients with HFrEF receiving GDMT showed significantly better survival than patients with cancer overall. The reported hazard ratio was 0.44 (95% CI 0.41–0.47; P\u003C0.001).","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did the study find for patients not receiving full GDMT compared with cancer?",{"text":68,"@type":64},"Patients not on full GDMT had higher mortality than patients with malignant cancers. The study reports a hazard ratio of 1.15 (95% CI 1.13–1.17; P\u003C0.001).",{"name":70,"@type":61,"acceptedAnswer":71},"Which sex-specific cancers showed better or worse survival relative to HFrEF on GDMT?",{"text":72,"@type":64},"Among common sex-specific cancers, only prostate and breast cancer had better survival than HFrEF on GDMT. Patients not on GDMT showed worse outcomes across most cancers, with the exception of lung cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367993,1790701527,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Journal of the American Heart Association  \nORIGINAL RESEARCH  \n\n| Comparative Mortality in Heart Failure on Guideline-Directed Medical Therapy Versus Malignant Cancer: A Report From a Global Federated Research Network\u003Cbr>Luca Monzo  , MD, PhD; Guillaume Baudry  , MD, PhD; Kevin Duarte  , PhD; Gema Hernandez  , PhD; Olivier Denquin, PhD; Gianluigi Savarese  , MD, PhD; Nicolas Girerd  , MD, PhD\u003Cbr>BACKGROUND: Guideline-directed medical therapy (GDMT), including angiotensin receptor-neprilysin inhibitor, angiotensinconverting enzyme inhibitors, beta blockers, mineralocorticoid receptor antagonists, and sodium-glucose cotransporter-2 inhibitors, has significantly improved outcomes in patients with heart failure with reduced ejection fraction (HFrEF) . We examined whether modern GDMT alters the historically observed parity in mortality between HF and cancer.\u003Cbr>METHODS: From the TriNetX Global Collaborative Research Network (2015–2024), we identified 32 125 patients with HFrEF on GDMT (angiotensin receptor-neprilysin inhibitor or angiotensin-converting enzyme inhibitors, mineralocorticoid receptor antagonists, beta blockers, and sodium-glucose cotransporter-2 inhibitors), 403 389 not on full GDMT (not receiving all 4 drugs concurrently), and 2 481 106 with malignant cancers. All-cause mortality was compared between HFrEF and cancer overall and across the most common cancers in men (prostate, colorectal, lung) and women (breast, lung, colorectal) using propensity score matching.\u003Cbr>RESULTS: Patients with HFrEF on GDMT with angiotensin receptor-neprilysin inhibitors had significantly better survival than patients with cancer (hazard ratio [HR], 0.44 [95% CI, 0.41–0.47]; P\u003C0 .001) . A survival benefit, though less pronounced, was also seen for GDMT with angiotensin-converting enzyme inhibitors instead of angiotensin receptor-neprilysin inhibitor (HR, 0.62 [95% CI, 0.57–0.69]; P\u003C0 .001) . Patients not on GDMT had higher mortality than patients with cancer (HR, 1.15 [95% CI, 1.13–1.17]; P\u003C0 .001) . Among the most common sex-specific cancers, only patients with prostate and breast cancer had better survival than those with HFrEF on GDMT, whereas patients not on GDMT showed worse outcomes across most cancers, except lung cancer.\u003Cbr>CONCLUSIONS: In this large real-world analysis, patients with HFrEF on GDMT showed better survival than those with cancer overall and across most sex-specific cancers. Patients not on GDMT experienced worse outcomes, emphasizing the need to optimize treatment in HFrEF.\u003Cbr>Key Words: cancer ■ guideline-directed medical therapy ■ heart failure with reduced ejection fraction ■ mortality |  |\n| --- | --- |\n| Cardiovascular diseases and cancer are the lead\u003Cbr>ing contributors to morbidity and mortality world\u003Cbr>wide,1 with heart failure (HF) standing out as a | major global health challenge within the spectrum of\u003Cbr>cardiovascular conditions.2 Although the incidence of\u003Cbr>HF has stabilized or declined in high-income countries |\n\nCorrespondence to: Luca Monzo, MD, PhD, Centre d’Investigation Clinique Plurithématique, INSERM 1433, Rue du Morvan, CHRU de Nancy, Institut de Recherche et d’Innovation en Santé (I. R. I.S.), Nancy, France. Email: [l.monzo@tiscali.it](l.monzo@tiscali.it)  \nThis article was sent to Sakima Ahmad Smith, MD, MPH, Associate Editor, for review by expert referees, editorial decision, and final disposition. Supplemental Material is available at [https://www.ahajournals.org/doi/suppl/10.1161/JAHA.125.044046](https://www.ahajournals.org/doi/suppl/10.1161/JAHA.125.044046)[ ](https://www.ahajournals.org/doi/suppl/10.1161/JAHA.125.044046)[For Sources of Funding and Disclosures](For Sources of Funding and Disclosures) , see page 9.  \n© 2025 The Author(s) . Published on behalf of the American Heart Association, Inc. , by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the o","cbCaiixfFe34Ven4","https://ap.wps.com/l/cbCaiixfFe34Ven4","pdf",1090672,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Clinical Perspectives\n## What Is New?\n## What Are the Clinical Implications?","[{\"question\":\"How does guideline-directed medical therapy (GDMT) affect mortality versus malignant cancer in HFrEF?\",\"answer\":\"Patients with HFrEF receiving GDMT showed significantly better survival than patients with cancer overall. The reported hazard ratio was 0.44 (95% CI 0.41–0.47; P\\u003c0.001).\"},{\"question\":\"What did the study find for patients not receiving full GDMT compared with cancer?\",\"answer\":\"Patients not on full GDMT had higher mortality than patients with malignant cancers. The study reports a hazard ratio of 1.15 (95% CI 1.13–1.17; P\\u003c0.001).\"},{\"question\":\"Which sex-specific cancers showed better or worse survival relative to HFrEF on GDMT?\",\"answer\":\"Among common sex-specific cancers, only prostate and breast cancer had better survival than HFrEF on GDMT. Patients not on GDMT showed worse outcomes across most cancers, with the exception of lung cancer.\"}]","Comparative Mortality in Heart Failure on Guideline-Directed Medical Therapy Versus Malignant Cancer - Original Research | PDF",1790174233,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c33d966d9be3a9726ad2513065535214.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11274a5dc95279a18ef6c39b3cfcc384.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e7538db426e66f21d7734cf9f63b7d7.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f30a4ac7f492489ca04f821519552df4.webp",980,1287]